Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2543376522;76523;76524 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
N2AB2379271599;71600;71601 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
N2A2286568818;68819;68820 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
N2B1636849327;49328;49329 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
Novex-11649349702;49703;49704 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
Novex-21656049903;49904;49905 chr2:178569835;178569834;178569833chr2:179434562;179434561;179434560
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Fn3-73
  • Domain position: 29
  • Structural Position: 31
  • Q(SASA): 0.3158
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 N 0.842 0.607 0.322786055943 gnomAD-4.0.0 3.18373E-06 None None None None I None 0 0 None 0 5.55031E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.9449 likely_pathogenic 0.9499 pathogenic -0.391 Destabilizing 1.0 D 0.745 deleterious N 0.513810903 None None I
G/C 0.9881 likely_pathogenic 0.9871 pathogenic -0.749 Destabilizing 1.0 D 0.811 deleterious N 0.521661716 None None I
G/D 0.9958 likely_pathogenic 0.9958 pathogenic -0.646 Destabilizing 1.0 D 0.842 deleterious N 0.501276055 None None I
G/E 0.9974 likely_pathogenic 0.9971 pathogenic -0.799 Destabilizing 1.0 D 0.869 deleterious None None None None I
G/F 0.9987 likely_pathogenic 0.9986 pathogenic -1.041 Destabilizing 1.0 D 0.812 deleterious None None None None I
G/H 0.9982 likely_pathogenic 0.9978 pathogenic -0.7 Destabilizing 1.0 D 0.821 deleterious None None None None I
G/I 0.9985 likely_pathogenic 0.9984 pathogenic -0.426 Destabilizing 1.0 D 0.823 deleterious None None None None I
G/K 0.9977 likely_pathogenic 0.9971 pathogenic -0.909 Destabilizing 1.0 D 0.87 deleterious None None None None I
G/L 0.9978 likely_pathogenic 0.9979 pathogenic -0.426 Destabilizing 1.0 D 0.838 deleterious None None None None I
G/M 0.9987 likely_pathogenic 0.9987 pathogenic -0.383 Destabilizing 1.0 D 0.809 deleterious None None None None I
G/N 0.9952 likely_pathogenic 0.9948 pathogenic -0.468 Destabilizing 1.0 D 0.819 deleterious None None None None I
G/P 0.9996 likely_pathogenic 0.9997 pathogenic -0.378 Destabilizing 1.0 D 0.852 deleterious None None None None I
G/Q 0.997 likely_pathogenic 0.9965 pathogenic -0.761 Destabilizing 1.0 D 0.848 deleterious None None None None I
G/R 0.9904 likely_pathogenic 0.9878 pathogenic -0.442 Destabilizing 1.0 D 0.852 deleterious N 0.482032938 None None I
G/S 0.9297 likely_pathogenic 0.9264 pathogenic -0.634 Destabilizing 1.0 D 0.814 deleterious N 0.507770515 None None I
G/T 0.9935 likely_pathogenic 0.9938 pathogenic -0.717 Destabilizing 1.0 D 0.867 deleterious None None None None I
G/V 0.9965 likely_pathogenic 0.9965 pathogenic -0.378 Destabilizing 1.0 D 0.842 deleterious N 0.521408227 None None I
G/W 0.997 likely_pathogenic 0.9958 pathogenic -1.225 Destabilizing 1.0 D 0.822 deleterious None None None None I
G/Y 0.9977 likely_pathogenic 0.9977 pathogenic -0.87 Destabilizing 1.0 D 0.808 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.